Skip to main content
The BMJ logoLink to The BMJ
. 1990 Sep 1;301(6749):422–423. doi: 10.1136/bmj.301.6749.422

Decreased salivary epidermal growth factor in rheumatoid disease: a possible mechanism for increased susceptibility to gastric ulceration.

S M Kelly 1, J Crampton 1, J O Hunter 1
PMCID: PMC1663684  PMID: 2282399

Full text

PDF
422

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Collins A. J., Du Toit J. A. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol. 1987 Aug;26(4):295–298. doi: 10.1093/rheumatology/26.4.295. [DOI] [PubMed] [Google Scholar]
  2. Farah D., Sturrock R. D., Russell R. I. Peptic ulcer in rheumatoid arthritis. Ann Rheum Dis. 1988 Jun;47(6):478–480. doi: 10.1136/ard.47.6.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Olsen P. S., Poulsen S. S., Kirkegaard P., Nexø E. Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology. 1984 Jul;87(1):103–108. [PubMed] [Google Scholar]
  4. Roth S. H. NSAID and gastropathy: a rheumatologist's review. J Rheumatol. 1988 Jun;15(6):912–919. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES